Feasibility of radiation dose reduction using AIDR-3D in dynamic pulmonary CT perfusion. by Mirsadraee, Saeed et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Feasibility of radiation dose reduction using AIDR-3D in dynamic
pulmonary CT perfusion.
Citation for published version:
Mirsadraee, S, Weir, N, Connolly, S, Murchison, JT, Reid, JH, Hirani, N, Connell, M & van Beek, EJR 2015,
'Feasibility of radiation dose reduction using AIDR-3D in dynamic pulmonary CT perfusion.' Clinical
Radiology, vol. 70, no. 8, pp. 844–851. DOI: 10.1016/j.crad.2015.04.004
Digital Object Identifier (DOI):
10.1016/j.crad.2015.04.004
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Clinical Radiology
Publisher Rights Statement:
This is the author's final manuscript as accepted for publication.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Clinical Radiology
 
Feasibility of radiation dose reduction using AIDR-3D in dynamic pulmonary CT
perfusion.
--Manuscript Draft--
 
Manuscript Number: CRAD-D-14-00975R1
Full Title: Feasibility of radiation dose reduction using AIDR-3D in dynamic pulmonary CT
perfusion.
Article Type: Original Paper
Corresponding Author: Saeed Mirsadraee, PhD, FRCR
University of Edinburgh
Edinburgh, UNITED KINGDOM
Corresponding Author Secondary
Information:
Corresponding Author's Institution: University of Edinburgh
Corresponding Author's Secondary
Institution:
First Author: Saeed Mirsadraee, PhD, FRCR
First Author Secondary Information:
Order of Authors: Saeed Mirsadraee, PhD, FRCR
Nicholas W Weir, PhD
Stuart Connolly, MBBS
John T Murchison, PhD FRCR
John H Reid, FRCR
Nikhil Hirani, MRCP PhD
Martin Connell, BSc
Edwin J van Beek, PhD FRCR
Order of Authors Secondary Information:
Abstract: Abstract
Aim: To assess the feasibility of radiation dose reduction with Adaptive Iterative Dose
Reduction (AIDR-6 3D) reconstruction in dynamic pulmonary CT perfusion (CTP).
Materials and Methods: CTP examinations of 10 patients acquired at 100kVp/50mAs
were reconstructed with Filtered Back Projection (FBP) and AIDR-3D. Artificial noise
was added to raw data (pre-reconstruction projection data) to simulate lower tube
current scanning. Hounsfield units (HU), noise, and perfusion values were compared.
Results: There was no significant difference in noise between the full and simulated
reduced tube current with AIDR-3D reconstruction (p=1). There was significantly lower
noise in lung tissue with AIDR-3D images when compared to reconstructions without
AIDR-3D (p=0.005) and no significant change in HU (p=1; mean difference <6HU).
Mean perfusion values increased significantly at lower tube currents (25 and 12.5mAs),
compared to 50mAs (p=0.005). This effect was significantly greater in larger patients
compared to thin patients.
Conclusion: AIDR-3D produced significantly lower noise images than FBP-based
algorithms and maintained consistent noise levels in lung at 12.5mAs, indicating this
algorithm is suitable for reduced dose lung perfusion imaging. Iterative reconstruction
allows significant radiation dose reduction of up to four fold in smaller patients, and up
to 2 fold in the medium/large size patients. The increase in perfusion values at 25%
simulated tube currents is attributed to attenuation bias.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Feasibility of radiation dose reduction using AIDR-3D in 
dynamic pulmonary CT perfusion.  
 
1. Saeed Mirsadraee, MD PhD FRCR 
Senior Lecturer in Radiology 
Clinical Research Imaging Centre 
Queen's Medical Research Institute 
University of Edinburgh 
47 Little France Crescent 
Edinburgh EH16 4TJ 
United Kingdom 
 
2. Nicholas W Weir, PhD 
Medical Physicist 
Department of Radiology 
Royal Infirmary of Edinburgh 
51 Little France Crescent, Edinburgh EH16 4SA 
 
3. Stuart Connolly 
Medical Student 
University of Edinburgh 
47 Little France Crescent 
Edinburgh EH16 4TJ 
United Kingdom 
 
4. John T Murchison, MBBS PhD FRCR 
Consultant Radiologist 
Title Page
Department of Radiology 
Royal Infirmary of Edinburgh 
51 Little France Crescent, Edinburgh EH16 4SA 
 
5. John H Reid, MD FRCR 
Consultant Radiologist 
Clinical Research Imaging Centre 
Queen's Medical Research Institute 
University of Edinburgh 
47 Little France Crescent 
Edinburgh EH16 4TJ 
United Kingdom 
 
6. Nikhil Hirani, MD PhD MRCP 
Senior Lecturer in Respiratory Medicine 
Queen's Medical Research Institute 
University of Edinburgh 
47 Little France Crescent 
Edinburgh EH16 4TJ 
United Kingdom 
 
7. Martin Connell, BSc  
Image Analysis Scientist 
Clinical Research Imaging Centre 
Queen's Medical Research Institute 
University of Edinburgh 
47 Little France Crescent 
Edinburgh EH16 4TJ 
United Kingdom 
  
8. Edwin J van Beek, MD PhD FRCR 
Professor of Radiology 
Clinical Research Imaging Centre 
Queen's Medical Research Institute 
University of Edinburgh 
47 Little France Crescent 
Edinburgh EH16 4TJ 
United Kingdom 
 
 
Corresponding Author: 
 
Dr Saeed Mirsadraee 
Senior Lecturer in Radiology 
Clinical Research Imaging Centre 
Queen's Medical Research Institute 
University of Edinburgh 
47 Little France Crescent 
Edinburgh EH16 4TJ 
United Kingdom 
 
phone +44-131-2427768 
fax +44-131-2427773 
saeed.mirsadraee@ed.ac.uk 
 
Acknowledgments:  
This work is supported by a research grant from Chest, Heart, Stroke Scotland.   
Short running head: Low dose CT perfusion using AIDR-3D. 
 
 
Author Contributions  
 
1. guarantor of integrity of the entire study 
2. study concepts and design 
3. literature research 
4. clinical studies 
5. experimental studies / data analysis 
6. statistical analysis 
7. manuscript preparation 
8. manuscript editing 
 
1. Saeed Mirsadraee: 1,2,3,4,5,6,7,8 
2. Nicholas: 2,3,5,6,7,8 
3. Stuart Connolly: 2,3,4,5,7,8 
4. John T Murchison: 2,4,7,8 
5. John H Reid: 2,4,7,8 
6. Nikhil Hirani: 2,4,7,8 
7. Martin Connell: 2,3,4,5,7,8 
8. Edwin J van Beek: 2,4,7,8 
 
Author Contributions
We truly appreciate comments from the reviewers. Please see the response to 
the comments and the related changes in the manuscript. 
REVIEWER 1 
Comment 1: The use of pvalue >0.05 to establish no significant difference may be a 
result of the power of the study, this should be addressed. 
Response: Thank you for this valuable comment. In this study, the calculated  
non-significant p-values ranged between 0.1-1. We have revised the results and 
exact p-values are included (p-values are highlighted in red).  
Comment  2: Does the increase mean perfusion values pose a problem in perfusion 
interpretation? 
Response: An increase in calculated mean perfusion can result in under- 
estimation of perfusion changes that may affect patient management. A comment 
has been added in the discussion (lines 289-290) to address this important 
question.  
 
Comment 3: line 69 type "does" - "dose" 
Response: Corrected. Line 72 
 
Comment 4: line 232 "sinogram bins" I do not understand this term 
Sinogram refers to the array of raw data projection measurements. For 
clarification, “sinogram bins” is replaced by with “raw data projection sinogram 
values” (Lines 276 and 283) 
 
Anonymous list of revisions
REVIEWER 2 
Comment 1: The extremely small sample size confines this investigation to a "proof 
of concept" investigation at present. It is hard to draw any meaningful comparisons 
from the statistical analyses, despite the interesting trends. The use of the 
simulated, rather than actual, different tube currents makes the results harder to 
extrapolate to clinical practice.  
Response: 
We agree with the reviewer that the data used for dose simulation were selected 
from a relatively small sample group. This potential limitation has been 
acknowledged in the discussion (line 305).  
The application of noise simulation allowed understanding of the effect of tube 
current reduction on image quality and perfusion quantification. The only 
alternative to this experimental study would be to perform multiple perfusion 
scans with different exposure factors. This will expose human subjects to 
significant risk from radiation exposure and using a validated simulation 
technique is a logical first step. The phantom study demonstrated little variation 
in HU of the contrast insert, air hole, and tissue material (fat), when comparing 
values from the real and simulated low dose studies (differences everywhere < 4 
HU) (Lines 188-190 in results section). The results of this study provide 
researchers with important information that would be used in testing strategies 
in reducing radiation dose in human subjects. 
A sentence has been added to the discussion to further emphasis on the above 
mentioned points (lines 297-301). 
Comment 2: Some questions regarding the validation phase of the simulation are 
also raised: 
-Was the phantom a standard thorax phantom?  
Response: 
 We used a PRM Verification body Phantom, Varian Medical Systems, Palo Alto, 
USA (37x32cm, medium body size equivalent). We used this phantom since it is 
designed for checking HU of inserts spanning a range of densities (eg. iodine 
contrast at predetermine concentration). Details of the phantom are updated in 
the methods and materials.  (Line 97) 
 
-Were ROIs measured at different z-axis (i.e. craniocaudal) positions to account 
for variation in noise by the adaptive dose reduction strategies used by standard 
CT, when scanning a real patient? In other words, did the noise filter add noise 
uniformly to the study or did its model account for variations introduced by 
adaptive dose modulation. This is important because although no significant 
difference was found in HU was found in the various measured tissues for the 
simulated against actual reduced tube current images, there could be variations 
in the real and simulated scans if different levels were analysed. 
Response: Being a volume scan, the tube current was constant and therefore no 
automatic tube current modulation was used. Therefore the noise addition 
software did not need to adapt for this factor. This is clarified in the methods 
section (Lines 86-88). 
Comment 3: Current dose reduction strategies also incorporate reduced tube 
potential (as acknowledged in the discussion)- this is an important area not 
explored in this investigation. 
Response: This limitation has been being addressed in the discussion (line 301-
303). Currently, there is no noise stimulation software to simulate lower tube 
voltages. 
Comment 4: With such a small study sample, was it appropriate to use parametric, 
rather than non-parametric, statistical tests for comparisons? 
Response: We have re-calculated p-values using non-parametric equivalent to 
paired t-test (Wilcoxon Signed Ranks test). The updated p-values are included in 
the results. Whilst there are changes in the absolute p-values, statistical 
significances remain unchanged (p-values are highlighted in red). 
The data met the requirement of ANOVA (Shapiro-Wilk normality test p-value 
>0.3); visualisation of their histograms demonstrated the data was 
approximately normally distributed).  
 
Comment 5: 
Introduction 
page 3, line 70: "The aim of this study was to assess the effectiveness of iterative CT 
image reconstruction techniques?" this is inaccurate; only one method of several IR 
techniques has been studied here. 
Response: Point taken, “iterative CT image reconstruction techniques “ is 
replaced by the specific type of IR used in this study (AIDR-3D): Line 75. 
 
Comment 6:  
Methods 
*     "Patient size was graded thin, medium, and large when the lower thoracic 
width was <32cm, 32-38cm , and >38cm, respectively". Were these 
categorisations arbitrarily decided, or is there precedent for their use? 
Response: The patient’s lateral width at the level of liver on the CT projection 
has been used as an index for categorising body sizes and determining exposure 
fctors (McCollough Radiographics. 2006;26(2):503). The average adult patient in 
our series was considered to have a lateral width of 34–40 cm. Patients with a 
lateral width of less than 32 cm were considered thin, and those with a lateral 
width of more than 38 cm were considered large. This was adapted from the 
COPDGene study methodology. Please find attached the standard operation 
procedure used in the COPDGene study. Unfortunately, this was never published 
in full in any publications, but you will see that COPDGene adopted the IPF-NET 
protocol when it comes to sizing of patients based on the CT scout film. We have 
adopted the same principle for our CT perfusion work. (information provided by 
Prof Edwin van Beek, previously a co-investigator of the  COPDGene study).  
The paragraph is revised to further clarify (line 152-155). This now reads:  
Lateral thoracic width (LTW) was measured on AP scanograms at the cardiac-
diaphragm interface (at the level of liver). Based on the average LTW in our 
cohort, patient size was graded thin, medium, and large, when the LTW was 
<32cm, 32-38cm, and >38cm, respectively. 
 
Comment 7: The section on the mean perfusion values (page 9, lines 186-197) is 
quite confusing and could be better summarised. 
 
Response: The section is revised as suggested to better project the results (Lines 
220-224). 
Comment 8: The term "bias" is used to describe the differences in PA HU values 
from thin to large patients, in Figure 2. Was this a qualitative interpretation? If not, 
how was bias calculated? 
 
Response: To clarify, the word bias is replaced by “the change in Hounsfield 
units”. Please see revised legends for figure 2.   
Comment 9: Discussion 
It would be useful to discuss alternatives for spectral imaging as well, such as dual-
energy CT acquisition. 
 
Response: The aim of this study was to investigate the feasibility of dose 
reduction in pulmonary perfusion imaging by tube current reduction. The 
perfusion technique used in this study only applies single energy imaging and 
the discussion of dual energy techniques is less relevant. When publishing the 
results of the main research data, eg. evaluation of perfusion changes in specific 
lung pathologies, we will discuss the pros and cons of each imaging technique.  
 
Comment 10:  
Highlights 
*     The first 2 points are not really highlights of the current investigation. 
Response: The first 2 points are revised to better highlight the aims of this study 
(please see the relevant section: Highlights). 
 
REVIEWER 3 
Well written paper. (Thank you) 
 
Comment 1: P9 Results "the mean PBF". Abbreviation not clarified earlier in text. 
Response: Abbreviation is now defined in line 220. 
 
Comment 2: P10 discussion, (3rd line from bottom) - ;an or and an "updated 
version of the iterative??" 
Sentence is revised: line 265-266. 
 
Comment 3: P11 discussion, 2nd line - add space between to and 50mAs 
Response: Space added. (line 271) 
 
Comment 4:  Highlights; last line - There is a limit to what/ how low the dose 
Response: Revised. The sentence now reads:  There is a limit to how low the 
dose can be reduced before the bias effect falsifies the calculated perfusion 
values.  
 
Abstract  
Aim: To assess the feasibility of radiation dose reduction with Adaptive Iterative Dose 
Reduction (AIDR-6 3D) reconstruction in dynamic pulmonary CT perfusion (CTP). 
 
Materials and Methods: CTP examinations of 10 patients acquired at 100kVp/50mAs 
were reconstructed with Filtered Back Projection (FBP) and AIDR-3D. Artificial noise 
was added to raw data (pre-reconstruction projection data) to simulate lower tube 
current scanning. Hounsfield units (HU), noise, and perfusion values were compared. 
 
Results: There was no significant difference in noise between the full and simulated 
reduced tube current with AIDR-3D reconstruction (p=1). There was significantly lower 
noise in lung tissue with AIDR-3D images when compared to reconstructions without 
AIDR-3D (p=0.005) and no significant change in HU (p=1; mean difference <6HU). Mean 
perfusion values increased significantly at lower tube currents (25 and 12.5mAs), 
compared to 50mAs (p=0.005). This effect was significantly greater in larger patients 
compared to thin patients.  
 
Conclusion: AIDR-3D produced significantly lower noise images than FBP-based 
algorithms and maintained consistent noise levels in lung at 12.5mAs, indicating this 
algorithm is suitable for reduced dose lung perfusion imaging. Iterative reconstruction 
allows significant radiation dose reduction of up to four fold in smaller patients, and up 
to 2 fold in the medium/large size patients. The increase in perfusion values at 25% 
simulated tube currents is attributed to attenuation bias. 
 
Revised Abstract
Feasibility of radiation dose reduction using AIDR-3D in 1 
dynamic pulmonary CT perfusion. 2 
 3 
 4 
Introduction  5 
Dynamic computed tomography pulmonary perfusion imaging is an emerging 6 
technology that may be utilised in the evaluation of true pulmonary perfusion in 7 
patients with various clinical disorders such as pulmonary hypertension and lung 8 
cancer [1,2]. The multiple CT series involved will expose patients to cumulative amounts 9 
of ionising radiation and every measure should be undertaken to reduce the dose in 10 
these potentially high radiation dose investigations. 11 
 12 
Iterative reconstruction algorithms offer the advantage of lowering radiation exposure 13 
whilst maintaining image quality [3]. These technologies are more advanced than post-14 
processing image blurring with Gaussian filters, which simply smooth noise and edges 15 
indiscriminately, and employ edge-preserving noise reducing algorithms. The most 16 
commonly used non-iterative (analytic) image reconstruction technique is filtered back 17 
projection (FBP) [4,5]. The acquired projection data are first filtered to compensate for 18 
the blurring inherent in the back projection process. However, the projection data from 19 
the scanners are noisy and this noise may be further amplified following filtering [5,6]. 20 
The characteristics of this reconstruction filter, or kernel, may be chosen to preserve 21 
high spatial frequency information to a greater or lesser degree, resulting in sharper or 22 
smoother images associated with higher- and lower noise levels respectively. 23 
 24 
The major advantage of iterative reconstruction techniques is that they produce much 25 
better image quality than FBP in the setting of a very low signal-to-noise ratio at the 26 
Revised Manuscript
detector [5]. As a result, radiation dose may be reduced whilst image quality is 27 
maintained [5]. The AIDR-3D (Adaptive Iterative Dose Reduction 3D) iterative 28 
reconstruction technique utilises adaptive filtering in the image domain, applied 29 
iteratively, together with noise reduction in the raw data domain [7]. Adaptive filtering 30 
reduces noise with less blurring than images reconstructed with non-adaptive filtering. 31 
It was hypothesised that iterative reconstruction can be used to reduce radiation dose in 32 
dynamic contrast enhanced CT perfusion whilst maintaining the perfusion values. 33 
 34 
The aim of this study was to assess the effectiveness of AIDR-3D on image noise and to 35 
assess the effect on calculated pulmonary CT perfusion parametric map noise and 36 
perfusion parameters. Simulation of dose reduction through the addition of noise in 37 
pulmonary CT perfusion examinations was performed to determine the subsequent 38 
effects on image quality and quantitative interpretation. 39 
 40 
Materials and methods: 41 
 42 
Image acquisition and reconstruction:  43 
 44 
All imaging was performed on a 320-multidetector row CT scanner (Aquilion ONE, 45 
Toshiba Medical Systems, Nasushiobara, Japan). Images were obtained using volume 46 
scan mode. The tube current was constant and therefore automatic tube current 47 
modulation was switched off. AIDR-3D reconstructions were compared with Toshiba’s 48 
original filtered back projection technique (ORG) which was used both with and without 49 
the addition of Quantum Denoising Software (QDS+). QDS+ utilises non-iterative noise 50 
reduction in the image domain. The effect of reconstruction techniques on image noise 51 
was evaluated in two stages.  52 
 53 
Step 1: Validation of noise simulation. 54 
 55 
A phantom study was designed to validate the noise simulation function. A phantom 56 
(37x32cm, PRM Verification body Phantom, Varian Medical Systems, Palo Alto, USA) 57 
with an insert containing water with iodinated contrast agent to achieve a CT 58 
attenuation of approximately 600 HU (Iomeron 400, Bracco SPA, Milan, Italy; 59 
400mgI/mL) was scanned using our local lung perfusion CT protocol (100 kVp, 0.5-60 
second gantry rotation time, 512x512 matrix, FC17 kernel, 0.5 mm slice thickness, 0.5 61 
mm slice increment) at 200, 100, 50, and 25 mA, giving tube current- time products of 62 
100mAs, 50 mAs, 25 mAs, and 12.5 mAs, respectively. Artificial noise was added to the 63 
raw data from the 100 mAs acquisition to produce simulated reduced current scans at 64 
50, 25 and 12.5 mAs using an experimental software tool (NoiseAdd version 2.3, 65 
Toshiba Medical Systems) [6,8,9].  66 
 67 
Regions of interests (ROI; 2.6 cm in diameter) were drawn on 4 consecutive slices on 68 
exactly the same positions to measure mean HU and standard deviation (SD) within the 69 
contrast insert, air holes, and the phantom body (fat attenuation mimicking material). 70 
Values from the acquired and simulated low dose studies were compared. 71 
 72 
Step 2: Pulmonary perfusion studies.  73 
This is a sub-study from a pool of 50 research patients who prospectively underwent 74 
research dynamic first-pass CT to evaluate perfusion changes in emphysema, pulmonary 75 
fibrosis, and recent pulmonary embolism (3-6 months following the acute presentation 76 
that was proven by CT pulmonary angiography; CTPA). Ten data sets from the above 77 
pool were randomly chosen for the purpose of this study (8 with previous PE, 1 78 
emphysema, 1 idiopathic pulmonary fibrosis). The local research ethics committee 79 
approved these studies and informed written consents were obtained from all patients. 80 
 81 
The scans were performed during a single breath-hold at deep inspiration. Shallow 82 
abdominal breathing was permitted at the end stage of acquisition in patients who were 83 
unable to hold their breath for the entire perfusion CT data acquisition. Intermittent 84 
volume imaging was performed every 1.5 seconds (11 volumes in total) with 3 seconds 85 
delay after the start of intravenous contrast injection. 86 
 87 
Scans were performed with 16 cm z-axis coverage (320 x 0.5-mm collimation) with the 88 
lowest section at the level of the diaphragm, 100 kVp, 0.5s rotation, fixed tube current  89 
mA (tube current-time product 50 mAs), and reconstruction parameters as described 90 
above. A dual-head power injector (Stellant CT Injection Systems, Medrad, Warrendale, 91 
USA) was used for bolus injection of 70 mL iodinated contrast agent (Iomeron 400, 92 
Bracco SPA, Milan, Italy; 400mgI/mL) via a 16G antecubital vein catheter at a rate of 9 93 
mL/s, followed by 20 mL of saline solution at the same rate. The dose length product 94 
(DLP) for the above protocol was 540 mGy·cm, corresponding to an effective dose of 95 
7.56 mSv (conversion factor 0.014). 96 
All studies were reconstructed and analysed by an image analysis scientist with >20 97 
years experience in image reconstruction and registration techniques, and analysis of 98 
pulmonary perfusion studies. All images were reconstructed using QDS+ and AIDR-3D 99 
(highest level of iteration used; Strong). An additional reconstruction was made with 100 
original filtered back projection technique (ORG) as control. Subsequently, images from 101 
the dynamic pulmonary CT perfusion examinations were reconstructed with artificial 102 
noise added to raw data (pre-reconstruction projection data) to simulate lower tube 103 
current scanning at 25 and 12.5 mAs. This procedure was applied using the NoiseAdd 104 
software. These images were then aligned using Body Register software (Toshiba 105 
Medical Systems, Nasushiobara, Japan). This process attempts to compensate for any 106 
shift in image position caused by anatomical movement during the scan [10]. Parametric 107 
perfusion maps were then produced by single-input maximum slope model [11] using 108 
Body Perfusion software (Toshiba Medical Systems, Nasushiobara, Japan). 109 
 110 
Patients with various body sizes were included in this study to investigate the effect of 111 
patients’ body size on images noise and perfusion parameters. Lateral thoracic width 112 
(LTW) was measured on AP scanograms at the cardiac-diaphragm interface (at the level 113 
of liver) [12]. Based on the average LTW in our cohort, patient size was graded thin, 114 
medium, and large, when the LTW was <32cm, 32-38cm, and >38cm, respectively.  115 
Regions of interest (ROI) were placed on the lung CT images generated from the image 116 
sets reconstructed with each of the filter methods (ORG, QDS+, AIDR-3D) and also on the 117 
resulting perfusion maps. ROI diameter was 10 mm and visible vessels of >1mm 118 
diameter were avoided. Six ROIs were placed throughout the lungs of each patient to 119 
give a comprehensive assessment of lung perfusion, attenuation, and noise. Mean and 120 
SD of HU were recorded for each set of CT images. The mean and SD perfusion values 121 
(mL/100g/min) were recorded for each perfusion map. The SD was taken as an 122 
indication of image noise in each ROI. Analyze software (AnalyzeDirect, Kansas, USA) 123 
was used to define and store identical ROIs for lung tissue CT and perfusion maps in all 124 
reconstructions for each patient. The time attenuation curve corresponding to the 125 
pulmonary artery ROI was used to define the arterial input function in the perfusion 126 
analysis and was stored for each perfusion map analysed. Identical ROIs were used for 127 
the pulmonary artery for all reconstructions of a patient by using the store and recall 128 
ROI time information.  129 
To identify the potential effect of Gaussian blur function on the calculated perfusion 130 
values, mean perfusion values within ROIs on parametric perfusion maps that were 131 
produced with weak or medium Gaussian smoothing filter [13,14] were compared. 132 
 133 
Statistical analysis: 134 
All results were expressed as mean ± standard deviation (SD) unless indicated 135 
otherwise. Noise was calculated as the SD of the HU values within an ROI or, in the 136 
perfusion maps, the SD of the perfusion values within an ROI. Noise for each image 137 
reconstruction method and image type was compared using Wilcoxon Signed Ranks test 138 
or Analysis of Variance (ANOVA). The mean perfusion values were plotted using a 139 
Bland-Altman analysis to check for agreement in the means between the different 140 
reconstruction techniques and tube current levels [15]. SPSS for Windows (v10.0.1) and 141 
MedCalc statistical software (v9.6) were used for all statistical analysis. Statistical 142 
significance was established at a p-value of <0.05. 143 
 144 
Results 145 
The phantom study demonstrated little variation in HU of the contrast insert, air hole, 146 
and tissue material (fat), when comparing values from the real and simulated low dose 147 
studies (differences everywhere < 4 HU). There was no statistically significant difference 148 
in the measured densities of the contrast, air and fat material, when comparing values at 149 
100 mAs and 50 mAs. There was, however, a significant reduction in the Hounsfield 150 
values, when the tube current was reduced from 50 to 25, and 12.5 mAs. Such variation 151 
was greater for the measured contrast attenuation (mean difference 134-529 HU), 152 
compared to air (13-51 HU), or fatty tissue equivalent (4.6-16 HU) (p<0.001; ANOVA) 153 
(Table 1). 154 
There was a slight reduction in noise in the simulated images compared to the real 155 
reduced tube current images (mean difference: 3.1; range: 0.4-6.3 (Table 1). 156 
When evaluating the 10 CT scans of the thorax, there was no significant difference in the 157 
mean HU of lung between AIDR-3D, QDS+, and ORG at various tube currents (p=1, 158 
ANOVA; mean difference <6HU). There was significantly lower noise in lung tissue with 159 
AIDR-3D at simulated 12.5mAs, when compared to QDS+ or ORG at 50 mAs or 25 mAs 160 
(mean difference in SD=42-51; p<0.004, ANOVA). There was no significant difference in 161 
noise between the 3 tube current groups with AIDR-3D reconstruction (p=0.329, 162 
ANOVA) (Table 2). 163 
The mean pulmonary artery HU averaged over all subjects dropped by more than 164 
100HU with a simulated reduction in tube current from 25 mAs to 12.5 mAs for all three 165 
algorithms (Figure 1). Although this difference was not significant by analysis of 166 
variance, paired test analysis demonstrated a significant difference in HU between 50 167 
mAs and 12.5 mAs (p=0.05, Wilcoxon Signed Ranks test), but not between 50 mAs and 168 
25 mAs (p>0.15, Wilcoxon Signed Ranks test). Close examination of the data 169 
demonstrated that the variations were more significant in larger patients (mean 170 
difference= 196HU), when compared to medium (mean difference=71HU), and thin 171 
patients (mean difference=5HU) (Figure 2). 172 
Image noise level in the parametric perfusion maps was significantly lower with AIDR-173 
3D when compared to QDS+ or ORG reconstructions in all three tube current levels 174 
(p<0.05, Wilcoxon Signed Ranks test; Table 3). There was no significant difference in 175 
noise level between QDS+ and ORG reconstructions at 50 mAs (p=0.33, Wilcoxon Signed 176 
Ranks test). Noise level was not significantly different when comparing AIDR-3D at 25 177 
mAs compared to QDS+ at 50 mAs, and AIDR-3D at 12.5 mAs compared to QDS+ at 50 or 178 
12.5 mAs (p>0.24, Wilcoxon Signed Ranks test). 179 
The mean pulmonary artery blood flow (PBF) in the selected ROIs were 101.6 and 101.5 180 
mL/100g/min with QDS+ and AIDR-3D at 50 mAs, respectively. There was no significant 181 
statistical difference in mean perfusion values between AIDR-3D and QDS+ at 50 mAs 182 
(p=0.23, Wilcoxon Signed Ranks test) and the level of agreement was considered good 183 
(<5% in 9 patients; 25.8% in a large patient). Moreover, there was no significant 184 
difference in mean perfusion values with weak or medium Gaussian smoothing filter 185 
(p=0.374, Wilcoxon Signed Ranks test). 186 
 187 
The mean PBF increased to 105.8, and 126.8 mL/100g/min with AIDR-3D at 25 mAs 188 
and 12.5 mAs, respectively (p=0.005, Wilcoxon Signed Ranks test) (Figure 3). The mean 189 
differences between 50 and 12.5 mAs and 25 and 12.5 mAs were 4.3 (0.3-13) and 25.2 190 
mL/100g/min (1.1-71), respectively. The mean difference in perfusion values between 191 
50 mAs and 25 mAs was considered small (<9% increase in 9 patients and 23.8% 192 
increase in a large patient). However, the mean difference at 12.5 mAs was significantly 193 
larger and ranged between 1-90%. The average PBF changes were 3.5%, 20% and 51% 194 
in small, medium and large size patients, respectively (Figure 3-4). 195 
 196 
Discussion 197 
Dynamic pulmonary perfusion CT imaging promises a step forward in the investigation 198 
of pulmonary embolism and other diseases that affect pulmonary perfusion, such as 199 
lung cancer, and pulmonary hypertension [1,2,16]. It offers a comprehensive anatomical 200 
and functional examination of the lung parenchyma, pulmonary vessels and perfusion in 201 
a single CT examination.  202 
In this study, repetitive CT series exposed patients to a total effective dose of 7.56 mSv. 203 
Radiation exposure can increase the lifetime risk of cancer [17]. Computed tomography 204 
is the leading cause of radiation exposure in diagnostic imaging and there have been 205 
recent technical developments to reduce exposure [18,19].  206 
Iterative reconstruction has been demonstrated to reduce radiation dose while 207 
maintaining image quality at low dose. The current study evaluated the effect of 208 
iterative reconstruction (AIDR-3D) on image quality compared to traditional filtered 209 
back projection techniques (ORG with and without QDS+) and demonstrated significant 210 
noise reduction benefit from the application of iterative reconstruction compared to 211 
traditional FBP, both in native reconstructed images and derived parametric perfusion 212 
maps. Other studies have demonstrated similar results. In a comparison of AIDR- 3D and 213 
FBP in coronary CT angiography, AIDR-3D was demonstrated to reduce noise by an 214 
additional 22% compared to FBP [20]. In a lung CT study, AIDR-3D allowed for a dose 215 
reduction of 64.5% whilst still reducing noise when compared to FBP filtration in higher 216 
dose scans [21]. 217 
A recent study into the effectiveness of a previous version of the iterative algorithm, 218 
AIDR, in hepatic perfusion showed that AIDR was significantly better at reducing noise 219 
than the filtered back projection method, but not significantly better than QDS+ in either 220 
a standard dose group or a low dose (approximately 45% lower dose) group [22]. In 221 
comparison, the results of our study showed that AIDR- 3D significantly reduces noise in 222 
non-perfusion contrast enhanced CT images, whilst preserving agreement in the mean 223 
HU against the previous standard QDS+. The results of the two studies, however, are not 224 
directly comparable due to study design differences. The updated version of the 225 
iterative reconstruction which we used (AIDR-3D vs AIDR in previous study) has 226 
potential advantages compared to the previous version. Differences in the 227 
characteristics of the liver and lung are also factors which should be further investigated. 228 
 229 
In this study, there was a significant difference in the perfusion values from perfusion 230 
maps generated with AIDR-3D at 12.5 mAs, when compared to 50 mAs or 25 mAs. This 231 
differs from a study by Negi et al. which reported similar perfusion values in parametric 232 
perfusion maps in both low and high dose groups [20]. In our study, a significant 233 
reduction in Hounsfield units was demonstrated at tube current of 12.5 mAs in the 234 
pulmonary artery (but not in the lung tissue) which is thought to be CT number bias 235 
related to the increased percentage of non-positive raw data projection sinogram values 236 
at very low tube currents [23]. This effect can be expected to be greater for more highly 237 
attenuating structures. The phantom study also demonstrated similar reduction in HU at 238 
lower tube current, the reduction in values were far greater in dense contrast, compared 239 
to air and fat attenuation material. The bias effect can be seen in both the real and 240 
simulated low dose images. A greater noise variance in absolute terms must be added by 241 
the software to higher mAs data in order to simulate low mAs scanning and this can be 242 
expected to produce a similar number of non-positive raw data projection sinogram 243 
values as the real low mAs data.  244 
 245 
The reduction in pulmonary artery peak HU would result in increased perfusion values 246 
by maximum slope technique, which is calculated by dividing the maximum 247 
enhancement slope in the target tissue (lung) by the peak of input function (pulmonary 248 
artery) [11]. An increase in calculated mean perfusion can result in the under-249 
estimation of perfusion reduction that can potentially affect patient management. The 250 
current study also demonstrated much smaller variations in pulmonary artery peak 251 
enhancement and perfusion values at low tube current in patients with small thoracic 252 
width. This may indicate that very low dose perfusion studies are feasible in thin 253 
patients but further phantom studies or larger cohorts are necessary to define a dose 254 
regimen based on patients’ body habitus.  255 
 256 
The application of noise simulation allowed understanding of the effect of tube current 257 
reduction on image quality and perfusion quantification. Only alternative to this 258 
approach would be to perform multiple perfusion scans with different exposure factors. 259 
This will expose human subjects to significant risk from radiation exposure and using a 260 
validated simulation technique is a logical first step in testing our hypothesis.  A 261 
limitation of the image noise addition technique used in this study is that it only 262 
simulates reduction of the tube current and not tube potential. The benefits from AIDR-263 
3D in reduced tube potential examinations need to be investigated in other studies. 264 
Another limitation to this study is the sample size. Larger cohorts would be necessary 265 
before a dose saving regimen can be recommended for dynamic pulmonary CT 266 
perfusion studies. 267 
 268 
Conclusions 269 
This study demonstrated that AIDR-3D significantly reduces noise in contrast enhanced 270 
CT images and parametric perfusion maps compared to conventional FBP techniques. 271 
However, lowering tube current resulted in an overestimation of perfusion values due 272 
to HU bias effects associated with photon starvation. In order to avoid this effect, a 273 
reduced dose lung perfusion CT protocol would therefore need to take into account the 274 
patient’s body habitus. Designing patient specific imaging protocols with AIDR- 3D is 275 
feasible and according to this preliminary experience, would result in significant 276 
ionising radiation reduction, especially in small patients, enabling the application of this 277 
technique beyond the purely research environment within more routine clinical practice. 278 
279 
Figure and Table legends: 280 
Figure 1. Mean HU values and image noises in pulmonary artery by tube currents and 281 
image reconstruction technique. 282 
 283 
Mean HU was significantly lower in the 50 mAs and 25 mAs images compared to 12.5 284 
mAs, irrespective of reconstruction technique (p-value <0.05; paired t-test). 285 
  286 
AIDR-3D: adaptive iterative dose reduction- 3 dimensional; HU: Hounsfield unit; QDS+: 287 
quantum de-noising; ORG: Original (non-filtered); SD: standard deviation of mean HU 288 
values. 289 
 290 
Figure 2. The effect of patients’ body size on mean pulmonary artery (PA) Hounsfield 291 
units at low tube currents. 292 
A. The plot shows the changes in PA HU for each patient with various thoracic diameters 293 
at low tube currents (as compared to 50 mAs) for AIDR3D. The plot illustrate that the 294 
the change in Hounsfield units is dependent on both patient size and mAs. B. This plot 295 
shows the divergence in HU in the PA for the two groups of patients, large and small, as 296 
tube current is decreased in simulation. The change in Hounsfield units is less when 297 
images are reconstructed with AIDR3D than with QDS+ or ORG. 298 
LTW: lateral thoracic width (cm). 299 
 300 
Figure 3. Example of parametric pulmonary perfusion maps at various tube currents in a 301 
thin (top row) and large patient (bottom row). 302 
In the parametric map, black/dark blue, yellow/green, and red colour codes represent 303 
low, moderate, and high pulmonary blood flow. Arrows show areas with apparent 304 
perfusion abnormality in the posterior segment of the left lower lobe at 50mAs (A&D), 305 
25mAs (B&E), and 12.5mAs (C&F), respectively. Note that the severity of perfusion 306 
abnormality remains unchanged at low mAs in the thinner patient. In contrast, there is 307 
apparent over-estimation of perfusion at lower current in the larger patient. 308 
 309 
Figure 4. Analysis of agreement between pulmonary artery blood flow (PBF) 310 
measurements obtained following QDS+ and AIDR-3D reconstructions. 311 
A: AIDR-3D (50mAs) vs. QDS+ (50mAs); B: AIDR-3D (50mAs) vs. AIDR-3D (25mAs); C: 312 
AIDR-3D (50mAs) vs. AIDR-3D (12.5mAs); D: AIDR-3D (25mAs) vs. AIDR-3D (12.5mAs). 313 
The solid line shows the mean difference and the dotted lines show the 2 SD limits of 314 
agreement. SD: standard deviation. 315 
The limits of agreement were considered acceptable for clinical purposes when 316 
comparing AIDR-3D and QDS+ at same tube voltage (50mAs), and AIDR-3D at 50mAs vs. 317 
AIDR-3D at 25mAs. The difference between the mean perfusion values for AIDR-3D at 318 
50mAs or 25mAs and the 12.5mAs was much greater and clinically unacceptable in 319 
large patients. The analysis demonstrated overestimation of perfusion values at lower 320 
mAs. 321 
 322 
Table 1. Phantom validation of noise addition software. 323 
A: Hounsfield values (SD); B: image noise values (SD). 324 
All real and noise simulated studies were reconstructed with AIDR-3D. Mean values 325 
were measured within ROIs drawn in the same position on multiple sections (n=4) 326 
within contrast insert, air hole, and fat mimicking material. 327 
Whilst the above results shows acceptable variation in the measured Hounsfield units 328 
and image noise in the real and simulated images, there were significant reduction in 329 
the Hounsfield units (iodinated contrast and fat material), when the tube current was 330 
reduced below 50mAs (p<0.001; ANOVA). The change was more obvious with the dense 331 
contrast. 332 
AIDR-3D: adaptive iterative dose reduction- 3 dimensional. SD: standard deviation; SD: 333 
standard deviation; ROI: region of interest. 334 
 335 
 336 
Table 2. Mean HU values and image noises in 10 regions of interest in lung tissue by tube 337 
currents and image reconstruction technique. 338 
AIDR-3D: adaptive iterative dose reduction- 3 dimensional; QDS+: quantum de-noising; 339 
ORG: Original (non-filtered); HU: Hounsfield unit; SD: standard deviation of HU values. 340 
 341 
Table 3. Mean perfusion value (±SD) for lung tissue perfusion (mL/100g/min) by tube 342 
currents and image reconstruction technique. 343 
AIDR-3D: adaptive iterative dose reduction- 3 dimensional; HU: Hounsfield unit; QDS+: 344 
quantum de-noising; ORG: Original (non-filtered); SD: standard deviation of HU values. 345 
 346 
 347 
348 
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  100mAs 50mAs 
Simulated 
50mAs 
25mAs 
Simulated 
25mAs 
12.5mAs 
Simulated 
12.5mAs 
 Contrast insert 1180 (3) 1176 (1) 1176 (3) 1042 (4) 1040 (2) 679 (1) 647 (2) 
 Air -998 (1) -997 (1) -997 (1) -983 (1) -982 (1) -950 (1) -946 (1) 
 Soft tissue (fat) -99 (2) -99 (1) -99 (1) -104 (1) -104 (1) -114 (2) -115 (1) 
A 
 100mAs 50mAs 
Simulated 
50mAs 
25mAs 
Simulated 
25mAs 
12.5mAs 
Simulated 
12.5mAs 
 Contrast insert 39.8  (2) 44.0 (3) 41.5 (2) 63.6 (2) 63.2 (2) 65.3 (2) 59.0 (2) 
 Air 15.0 (1) 17.5 (3) 16.7 (1) 24.5 (1) 20.7 (2) 28.4 (1) 23.8 (1) 
 Soft tissue (fat) 20.2 (1) 24.8 (0) 22.0 (1) 28.0 (1) 22.9 (0) 32.2 (1) 27.2 (1) 
B 
Table 1. Phantom validation of noise addition software. 
A: Hounsfield values (SD); B: image noise values (SD).  
All real and noise simulated studies were reconstructed with AIDR-3D. Mean values 
were measured within ROIs drawn in the same position on multiple sections (n=4) 
within contrast insert, air hole, and fat mimicking material.  
Whilst the above results shows acceptable variation in the measured Hounsfield units 
and image noise in the real and simulated images, there were significant reduction in the 
Hounsfield units (iodinated contrast and fat material), when the tube current was 
reduced below 50mAs (p<0.001; ANOVA). The change was more obvious with the dense 
contrast.  
AIDR-3D: adaptive iterative dose reduction- 3 dimensional. SD: standard deviation; SD: 
standard deviation; ROI: region of interest.  
Tables
 Tube Current  AIDR-3D QDS+ ORG 
50 mAs HU -815.5 ± 53.8 -816.9 ± 53.5 -816.7 ± 53.5 
 SD 48.8 ± 8  85.9 ± 21.4 95.1 ± 28.2 
25 mAs HU -810.3 ± 54.9 -813.7 ± 53.8 -816.2 ± 52.1 
 SD 46.2 ± 7.5 101.8 ± 26.8 110.8 ± 32.5 
12.5 mAs HU -805.7 ± 54 -807.9 ± 54.2 -803.2 ± 58.1 
 SD 43.8 ± 6.7 118.4 ± 26 129.1 ± 32 
 
Table 2. Mean HU values and image noises in 10 regions of interest in lung tissue 
by tube currents and image reconstruction technique.  
AIDR-3D: adaptive iterative dose reduction- 3 dimensional; QDS+: quantum de-noising; 
ORG: Original (non-filtered); HU: Hounsfield unit; SD: standard deviation of HU values. 
 Tube Current AIDR-3D QDS+ ORG 
50 mAs 101.5 ± 174 101.6 ± 213 101.8 ± 214 
25 mAs 105.8 ± 212 107.6 ± 256 107.6 ± 264 
12.5 mAs 126.8 ± 275 133 ± 364 144.5 ± 386 
  
Table 3. Mean perfusion value (±SD) for lung tissue perfusion (mL/100g/min) by tube 
currents and image reconstruction technique.  
AIDR-3D: adaptive iterative dose reduction- 3 dimensional; HU: Hounsfield unit; QDS+: 
quantum de-noising; ORG: Original (non-filtered); SD: standard deviation of HU values. 
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CT ACQUISITION AT STUDY SITES 
A. Site survey 
An initial site survey (Appendix) will be performed to identify responsible personnel, CT 
scanner models, and image transmission preferences.  
 
B. Technologist training 
A Powerpoint training set will be implemented for technologists at the Clinical Centers to 
assure understanding of the outline of the study, and compliance with the radiology protocols. 
Each technologist involved in the acquisition of scans must be certified as having reviewed the 
training set. 
 
C. Scanner quality assurance 
At each study site, each CT scanner used in the study will be calibrated on a monthly basis, 
using the Catphan 600 phantom (to be purchased by each site), scanned using the study 
protocol parameters for small-size patients. The following parameters will be measured using 
this phantom: slice thickness; spatial resolution, low contrast resolution; image uniformity and 
noise; high-contrast spatial resolution accuracy of CT attenuation values for air, low density 
polyethylene, water, Teflon. These values will be reported to the Radiology core laboratory. 
 
D. Patient preparation 
Prior to the study, patient’s identity will be confirmed according to institutional policy. The 
patient will be informed of the importance of compliance with the breathing instructions. Ability 
to comply with instructions should be assessed, and conditions which might impair compliance 
such as deafness, breathlessness, or mental impairment should be noted. At least one 
rehearsal of the end-inspiratory breathhold should be performed. 
 
E. CT acquisition  
All CT scans will be obtained using the enclosed protocol (Protocols for GE 64-detector 
scanners and for Phillips scanners to be developed). Minimal criteria for study entry will include 
availability of a set of contiguous CT images obtained on inspiration, using scanners with 16 or 
more detector rows, and ≤ 1.25 mm thickness of reconstructed slices. Contiguous end-
expiratory CT images will also be obtained where possible. Additional reconstructions may be 
performed as required at study site, but only the contiguous thin section 1.25 mm images 
should be sent to the Core Laboratory.  
The responsible CT technologist should complete the CT acquisition form, and sign off on the 
quality of the study. 
 
F. Scan transmission 
All potentially identifying material should be removed from the DICOM header, and replaced 
with the participant’s study ID. The anonymized scan data, consisting of contiguous thin-
section 1.25 mm images should be written to CD or DVD, and sent to the Radiology Core 
Laboratory using express mail. An image shipment form (enclosed) should be faxed to the 
core laboratory, and a copy should be enclosed with the shipped images.  
IMAGE PROCESSING AT RADIOLOGY CORE LABORATORY  
 
A. PROCESSING/QUALITY ASSURANCE   
Anonymized images will be submitted on CDs to the image registry in DICOM format, using a 
study ID as the only identifier. Upon arrival at the radiology core laboratory at National Jewish 
Medical and Research Center, CT media will be processed by the research staff, to verify 
anonymization and appropriate identification of study information, protocol compliance, image 
quality, and image count. If quality issues are identified, the staff will complete a quality form 
and will contact the site to attempt resolution.  
 
B. QUANTITATIVE CT ANALYSIS  
Image segmentation 
Scans will be loaded to the image analysis workstation (Dell Precision Workstation 670 with dual 
Intel® Xeon™ Processors operating at 3.60GHz, 2MB L2 memory cache, 8 GB RAM, 250 GB 
SATA hard drive, and 20 inch monitor) for quantitative image analysis. Anonymized DICOM images 
will be segmented using the VIDA image analysis system developed at University of Iowa 
(http://www.vidadiagnostics.com). The software will be used to divide the right lung from the left 
lung, and each lung will be divided into two craniocaudal zones of equal height. Individual lung 
lobes will also be segmented. Images will be visually inspected for quality of segmentation.  
 
Quantification of emphysema 
The following analyses will be performed on the segmented lung images, and results provided to 
the DCC:  
• total inspiratory lung volume 
• mean lung attenuation 
• % lung area with attenuation coefficient < -950, -910 and -856 HU 
• % LAA (<-950 HU) in upper lungs and lower lungs 
• % LAA (<-950 HU) in upper lobes and lower lobes 
• % LAA (<-950 HU) in peripheral 50% of lung 
• % LAA (<-950 HU) in central 50% of lung 
• Hounsfield Unit values at each percentile from 1 to 16 
• α value (negative slope from the log-log relationship of hole size vs percentage of holes) 
(with hole membership defined as voxels at -950 HU, -910 HU, or -850 HU)  
• α value in upper lobes and lower lobes 
 
Analysis of airway abnormality 
The VIDA software will be used to generate a skeletonized model of the airways, following seed 
placement in the upper trachea. An automated iterative process will be used to correct defects in 
the segmented airway tree. Using a 3D curve-thinning algorithm, a centerline of the airway tree will 
be generated, then pruned and smoothed. The following airway analyses will be performed and 
reported: 
• Mean % wall area for third generation bronchi 
• Mean % wall area for fourth generation bronchi 
• Mean % wall area for fifth generation bronchi 
• Mean % wall area for sixth generation bronchi 
• For each patient, the square root of wall area of all bronchi will be plotted against the 
internal perimeter, to identify the intercept corresponding to a bronchus of 10 mm internal 
perimeter. The resultant value for square root of wall area will be the primary measure of 
airway wall thickness.  
 
C.  STORAGE  
Validated studies received by the core laboratory will be archived to a Dell Windows Server 
2003 RAID 5 (1.5 TB), with 6 GB memory, dual processors, and a gigabyte network interface. 
This server will be backed up to tape on a weekly basis, and backup tapes will be transported 
to an offsite location, For document storage, we will use a FireKing fireproof locking filing 
cabinet.  
 
D.  QUALITY ASSURANCE  
The consistent high quality acquisition of CT images is critical to the success of this study. 
Quality will be achieved in the following ways:  
A. Review of phantom scan data from clinical sites 
B. Visual evaluation of a subset of scans by a core laboratory radiologist for image quality, 
using the enclosed form. Specific attention will be paid to adequacy of inspiration, 
absence of motion artifact, or excessive noise, and adherence to study protocol, The 
first 10 scans from each site will be reviewed, followed by a 5% sample of scans. 
Quality problems will be communicated directly to the study site radiologist by the core 
laboratory. Persistent quality problems will mandate re-training of technologists at the 
study site. 
C. For quality assurance of the quantitative image analysis, 10% of scans will be re-
analyzed at University of Iowa using the same software, and the same subset will also 
be analyzed at Brigham and Women’s Hospital using the 3-D SLICER program.  
 
E. IMAGE ANALYSIS AT OTHER SITES  
The primary VIDA analysis will be performed at National Jewish; however, we also will take 
advantage of the extensive developmental work on airway imaging and quantification being done 
at the University of Iowa and at Brigham and Women’s Hospital. The collaborative interactions of 
these three image analysis groups will be used for: 1) quality control, 2) comparisons to 
nonsmoking and smoking control subjects (without airflow obstruction), and 3) development and 
validation of novel techniques for quantification of airway characteristics. A subset of CT scans will 
be reanalyzed at both the University of Iowa (using the VIDA program) and at Brigham and 
Women’s (using the 3D-SLICER program) for quality control purposes. CT-determined airway wall 
parameters have been well established on two-dimensional CT images to be correlated with COPD 
physiology and pathology. Three-dimensional assessment of airway wall dimensions offers the 
opportunity to quantitate greater numbers of airways with greater reliability and potentially lower 
cost. The collaboration between these three programs will allow our proposed COPD cohort to be 
analyzed with state-of-the-art CT image analysis techniques. The segmented image data will be 
available for re-analysis as new techniques are developed. 
 
F. DATA REPORTING: 
The following data will be reported to the DCC, preferably electronically:  
• Receipt of complete and technically adequate scan 
• Quantitative parameters outlined above 
• Quality assurance data 
 
G. APPENDICES 
 
1. SITE RADIOLOGY SURVEY 
 
2. CT PROTOCOL SHEET 
 
3. IMAGE ACQUISITION WORKSHEET 
 
4. IMAGE TRANSMISSION WORKSHEET 
 
5. IMAGE QUALITY WORKSHEET 
 
6. IMAGE TRACKING WORKSHEET 
Genetic Epidemiology of COPD  
Radiology Site Survey Form 
      
Version January 4, 2007  Page 1 of 3 
Please Complete the Form and Fax to COPD Imaging Lab  at 303 270 XXXX 
 
Personnel Contact Information  
 
Imaging Site name: _____________________________________________________________  
 
Imaging Site number: ____________________________________________________________  
 
Site address:  __________________________________________________________________  
________________________________________________________________  
________________________________________________________________  
Fax Number:   _________________________________________________________________  
 
Coordinator:   ________________________________________________ 
 
Telephone   _________________________  Email       
 
Primary Radiologist:   ________________________________________________ 
 
Telephone   _________________________  Email       
 
Backup Radiologist:________________________________________________ 
 
Telephone ___________________________  Email       
 
Primary CT Technologist:________________________________________________ 
 
Telephone ___________________________  Email       
 
Backup CT Technologist:________________________________________________ 
 
Telephone ___________________________  Email       
 
Physicist:________________________________________________ 
 
Telephone ___________________________  Email       
 
PACS Supervisor:________________________________________________ 
 
Telephone ___________________________  Email       
 
CT information 
Number of CT scanners: 1 ; 2 ; 3 ; >3    
 
_______________________________________________ 
 
Genetic Epidemiology of COPD  
Radiology Site Survey Form 
      
Version January 4, 2007  Page 2 of 3 
CT Information   Please list each scanner separately.  
 
Scanner 1 
 
Scanner Manufacturer:   GE , Siemens ,  Philips ,   other_________________________  
 
CT Model or Name (e.g.,Lightspeed, Sensation, etc.) __________________________________  
 
Number of detectors: 4 , 8 , 16 , 40 , 64 , other _____________________________  
 
Current Software Version:  _______________________________________________________  
 
Scanner 2 
 
Scanner Manufacturer:   GE , Siemens ,  Philips ,   other_________________________  
 
CT Model or Name (e.g.,Lightspeed, Sensation, etc.) __________________________________  
 
Number of detectors: 4 , 8 , 16 , 40 , 64 , other _____________________________  
 
Current Software Version:  _______________________________________________________  
 
Scanner 3 
 
Scanner Manufacturer:   GE , Siemens ,  Philips ,   other_________________________  
 
CT Model or Name (e.g.,Lightspeed, Sensation, etc.) __________________________________  
 
Number of detectors: 4 , 8 , 16 , 40 , 64 , other _____________________________  
 
Current Software Version:  _______________________________________________________  
 
Scanner 4 
 
Scanner Manufacturer:   GE , Siemens ,  Philips ,   other_________________________  
 
CT Model or Name (e.g.,Lightspeed, Sensation, etc.) __________________________________  
 
Number of detectors: 4 , 8 , 16 , 40 , 64 , other _____________________________  
 
Current Software Version:  _______________________________________________________  
 
Are there any planned upgrades or new scanner purchases within the next 4 years?  
Yes__    No   
 
Please provide details 
 
 
Genetic Epidemiology of COPD  
Radiology Site Survey Form 
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COPD Imaging Lab  at 303 270 XXXX 
 IPF-NET STUDY Volumetric HRCT Protocols GE / SIEMENS  
 
 
GENERAL: This study consists of 2 scouts (topograms) and 3 scans.  All scans use the same parameter grid. For the GE scanners the mA is set 
according to patient size, defined as follows: 
  
Lateral Thickness  
 at Level of Liver Size Definition
 
 < 32 cm............... Small (S) 
 32-38 cm............... Medium (M) 
 >38 cm............... Large (L) 
 
CONTRAST: Oral/IV.  None. 
 
SUPINE SERIES 
GE SCOUT:    Supine PA S0-I450; Scan from top of shoulder through mid-liver. 
SIEMENS TOPOGRAM:  Supine PA, 512mm. STOP SCAN when through lungs. 
 
SUPINE INSPIRATION: Start at bottom of lungs, end at top of lungs. Instruct the patient to breathe as follows: 
“For the first part of this study you will be asked to hold your breath in for about 20 seconds.  If you cannot hold your 
breath that long, try the best you can and then take very shallow, slow breaths if you need to.” 
“For now, take several easy, deep breaths and relax while we prepare to take a CT scan of your lungs.” 
Allow patient to breathe and relax for at least 15 seconds. 
“I am now going to give you specific breathing instructions. Try to follow as best you can.” 
“Take in a deep breath….and let it out.” 
“Take in another deep breath….and let it out.” 
“Take in another deep breath, and hold your breath in.  Keep holding your breath!”  
Scan the patient  in one breath-hold at full-inspiration. 
When the scan is completed, tell the study participant to “Breathe and relax!” 
 
SUPINE EXPIRATION: (Required only for baseline study- may either do continuous volumetric acquisition or 1 mm scans every 2 cm) 
  Same protocol as SUPINE INSPIRATION. Start at bottom of lungs, end at top of lungs.  
Instruct the patient to breathe as follows: 
“For the second part of this study you will be asked to blow out your breath and hold it out for about 20 seconds.  This 
is usually more difficult than holding your breath in, but do the best that you can.  If you cannot hold your breath 
out that long, take a very slow shallow breath in if you need to.” 
“For now, take several easy, deep breaths and relax while we prepare to take the last CT scan of your lungs.” 
Allow patient to breathe and relax for at least 15 seconds. 
“I am now going to give you more specific breathing instructions.  Try to follow as best you can. ” 
“Take in a deep breath….and let it out.” 
“Take in another deep breath….and let it out.” 
“Take in another deep breath, let it out and hold your breath all the way out!  Do not breathe!”  
Scan the patient in one breath-hold at full-expiration as quickly as possible. 
When the scan is completed, tell the study participant to “Breathe and relax!” 
 
PRONE SERIES 
Reposition Patient into Prone position on table. 
GE SCOUT:   Prone PA S0-I450; Scan from top of shoulder through mid-liver. 
SIEMENS TOPOGRAM:  Prone PA, 512mm. STOP SCAN when through lungs. 
 
PRONE INSPIRATION: (Required only for baseline study- may either do continuous volumetric acquisition or 1 mm scans every 2 cm)
Same protocol as SUPINE INSPIRATION. Start at bottom of lungs, end at top of lungs.  
Instruct the patient to breathe as follows: 
“For the first part of this study you will be asked to hold your breath in for about 20 seconds.  If you cannot hold your 
breath that long, try the best you can and then take very shallow, slow breaths if you need to.” 
“For now, take several easy, deep breaths and relax while we prepare to take a CT scan of your lungs.” 
Allow patient to breathe and relax for at least 15 seconds. 
“I am now going to give you specific breathing instructions. Try to follow as best you can.” 
“Take in a deep breath….and let it out.” 
“Take in another deep breath….and let it out.” 
“Take in another deep breath, and hold your breath in.  Keep holding your breath!”  
Scan the patient  in one breath-hold at full-inspiration. 
When the scan is completed, tell the study participant to “Breathe and relax!” 
 
SCAN TECHNIQUES: 
 
GE LS Ultra-8 LS 16 Sensation-16 Sensation-64 SIEMENS 
Scan Type Helical Helical Spiral Spiral Scan Type  
Rotation Time (s) 0.5 see mA 0.5 0.5 Rotation Time (s) 
Det. Configuration 8 x 1.25 16 x 0.625 16 x 0.75 64 x 0.6 Collimation 
Pitch 1.35 1.375 1.1 1.1 Pitch 
Speed (mm/rot) 13.5 13.75 13.2 21.1 Feed (mm/rot) 
kVp 140 140 140 140 kVp 
mA 
S: 130 
M: 255 
L: 380 
S:150 @ 0.5s 
M:300 @ 0.5s 
L:375 @ 0.6s 
110 
 
110 
 
Quality ref mAs 
 
Auto-mA OFF OFF ON ON CARE Dose 4D 
Breath-hold time for 
280 mm (sec) 11 
S or M:10.8 
L:12.9 10.6 7.44 
Breath-hold time for 
280 mm (sec) 
RECON 1     RECON JOB 1 
Algorithm STD/FULL STD/FULL B40f B40f Kernel 
Thickness (mm) 5 5 5 5 Slice (mm) 
Interval (mm) 5 5 5 5 Recon Incr. (mm) 
DFOV (cm) Patient Patient Patient Patient FOV (mm) 
RECON 2     RECON JOB 2 
Algorithm BONE /FULL BONE /FULL B46f B46f Kernel 
Thickness (mm) 1.25 1.25 1.0 1.0 Slice (mm) 
Interval (mm) 10 10 10 10 Recon Incr. (mm) 
DFOV (cm) Lungs* Lungs* Lungs* Lungs* FOV (mm) 
RECON 3     RECON JOB 3 
Algorithm BONE /FULL BONE /FULL B46f B46f Kernel 
Thickness (mm) 1.25 1.25 1.0 1.0 Slice (mm) 
Interval (mm) 0.625 0.625 0.5 0.5 Recon Incr. (mm) 
DFOV (cm) Lungs* Lungs* Lungs* Lungs* FOV (mm) 
Additional Information 
CTDIvol (mGy) 15.0 17.3 13.1 11.33 CTDIvol (mGy) 
Effective Dose (mSv) 6.6 8.3 6.4 6.1 Effective Dose (mSv)
* Set DFOV for Recon 2 and 3 “Lungs*” to include outside edge of the ribs. 
 
 
 
 AXIAL HIGH-RESOLUTION CHEST (IPF-NET) STUDY (LIMITED PROTOCOL)   
   
 
CONTRAST: Oral. None. 
IV. None. 
 
 
SERIES 1: GE Scout: Supine AP S0-I450; Scan from top of shoulder through mid-liver. 
 Siemens Topogram: Supine AP, 512mm. STOP SCAN when through lungs.  
 
 
SERIES 2: Start at bottom of lungs, end at top of lungs. End-inspiration. 
  
 
GE CT/i-1 LS QX/i-4 LS Plus-4 Volume Zoom SIEMENS 
Scan Type Axial Axial Axial Sequential Scan Type  
Rotation Time (s) 1 0.8 0.8 0.75 Rotation Time (s) 
Det. Configuration 1 x 1 1 x 1.25 1 x 1.25 1 x 1 Collimation 
Table Increment (mm) 10 10 10 10 Feed (mm/rot) 
kVp 140 140 140 140 kVp 
mA 240 330 330 200 ? Quality ref mAs 
Breath-hold (s) 10 10 10 10 Breath-hold (s) 
Breathe Time (s) 12 12 12 12 Breathe Time (s) 
RECON     RECON  
Algorithm BONE BONE BONE B46f Kernel 
Thickness (mm) 1.0 1.25 1.25 1.0 Width (mm) 
Interval (mm) 10 10 10 10 Interval (mm) 
DFOV (cm) Patient Patient Patient Patient DFOV (mm) 
Additional Information 
CTDI-vol (mGy) 1.9 10.1 10.1 3.1 ? CTDI-vol (mGy) 
Effective Dose (mSv) 0.9 4.7 4.7 1.3 ? Effective Dose (mSv)
 
 
 
 
 
                                Protocol IM 101-200 
 
Genetic Epidemiology of COPD
IMAGE ACQUISITION FORM 
This form is to be completed for each subject exam and submitted with the image data. 
Site # Subject ID1 Subject Initials 
__ __  __ __ __ __ __ __ 
 
1For phantom scans, include your site # and write ‘phantom’ in the Subject ID field. 
 
CT Scan Date:________________________ 
CT Technologist: _____________________  
Scanner manufacturer __________________ Scanner model: ___________________________________ 
Number of detectors ___________________ 
 
CT IMAGE ACQUISITION  
 
Completed Scan 
Reconstru
cted 
collimatio
n 
 
 Scout   
 INSPIRATION   
 EXPIRATION   
 
 
CT IMAGE QUALITY  
 
Adequate inspiration 
Motion artifact 
Inclusion of all parts of lungs 
 
TECHNOLOGIST SIGNATURE:       
 FORM VERSION 1/8/2007 
 
 
                                Protocol IM 101-200 
 
 
Genetic Epidemiology of COPD
IMAGE SHIPMENT FAX NOTIFICATION FORM 
 
TO: Radiology core laboratory COPD Imaging Research Laboratory Use Only 
National Jewish Medical and Research Center  
1400 Jackson Street 
Denver, CO 80206 
 
 
FAX #  1-303-270-XXXX 
 
FROM:  Site # _______________________  
 
P. I. _____________________________  
 
Contact Person: ______________________  
 
FAX # _____________________________   Approved 
   Conditional Approval (see attachments) 
Date Faxed: _________________________    Not Approved (see attachments) 
 
Shipment Type Subject ID1 Subject Initials CD DVD 
__ __ __ __ __ __   
__ __ __ __ __ __   
__ __ __ __ __ __   
__ __ __ __ __ __   
__ __ __  __ __ __   
 
1For test scans (non-patient), write ‘TEST’ in the Subject ID field. 
 
The above data is being sent to you today   ______________   (today’s date) 
 
Airbill # (FedEx, Airborne, DHL shipments only)  _________________________ 
 
 
                   Form completed by _________________________ 
Email _________________________ 
   Telephone _________________________  
 FORM VERSION 1/8/2007 
 
 
 
 
Genetic Epidemiology of COPD
CT QUALITY ASSURANCE WORKSHEET 
 
Patient ID    Date of study    
 
Reviewer ID    
 
Exam quality 
 
 No 
quality 
issue 
Minor 
quality 
issue 
Substantial 
impairment 
of quality 
Non-
diagnostic 
scan 
Comments 
Adequate 
inspiration 
     
Motion artifact      
Inclusion of all 
parts of lungs 
     
Adherence to study acquisition parameters:  
mA      
kVp      
Slice 
collimation 
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Highlights: 
Dynamic CT examinations provide functional information but at the cost of a 
higher radiation dose.  
Doses can be reduced by decreasing tube current but increases image noise. 
This study demonstrates that significant dose reduction is feasible when images 
are reconstructed with iterative reconstruction (AIDR-3D), especially in smaller 
patients.  
There is a limit to how low the dose can be reduced before the bias effect falsifies 
the calculated perfusion values. 
 
Highlights
